{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:13Z","timestamp":1786980193187,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06130-8","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:15:52Z","timestamp":1744802152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Heterogeneity in treatment response for patent ductus arteriosus: a meta-analysis"],"prefix":"10.1007","volume":"184","author":[{"given":"Felipe Yu","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera L\u00facia Jornada","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werther Brunow","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"6130_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0036-1593351","volume":"34","author":"A Lokku","year":"2017","unstructured":"Lokku A, Mirea L, Lee SK, Shah PS (2017) Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada. Am J Perinatol 34:441\u2013450","journal-title":"Am J Perinatol"},{"key":"6130_CR2","first-page":"CD013588","volume":"4","author":"S Mitra","year":"2023","unstructured":"Mitra S, de Boode WP, Weisz DE, Shah PS (2023) Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. Cochrane database Syst Rev. 4:CD013588","journal-title":"Cochrane database Syst Rev."},{"key":"6130_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJMoa2207418","volume":"388","author":"T Hundscheid","year":"2023","unstructured":"Hundscheid T et al (2023) Expectant management or early ibuprofen for patent ductus arteriosus. N Engl J Med 388:980\u2013990","journal-title":"N Engl J Med"},{"key":"6130_CR4","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"key":"6130_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5:1\u201310","journal-title":"Syst Rev"},{"key":"6130_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0197-2456(99)00026-4","volume":"20","author":"HD Clark","year":"1999","unstructured":"Clark HD et al (1999) Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 20:448\u2013452","journal-title":"Control Clin Trials"},{"key":"6130_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:1\u201313","journal-title":"BMC Med Res Methodol"},{"key":"6130_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"6130_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00431-020-03780-8","volume":"180","author":"C Dani","year":"2021","unstructured":"Dani C et al (2021) Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial. Eur J Pediatr 180:807\u2013816","journal-title":"Eur J Pediatr"},{"key":"6130_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jpeds.2011.12.031","volume":"160","author":"IRS Sosenko","year":"2012","unstructured":"Sosenko IRS, Fajardo MF, Claure N, Bancalari E (2012) Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr 160:929\u201335.e1","journal-title":"J Pediatr"},{"key":"6130_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamapediatrics.2020.1447","volume":"174","author":"SI Sung","year":"2020","unstructured":"Sung SI, Lee MH, Ahn SY, Chang YS, Park WS (2020) Effect of nonintervention vs oral ibuprofen in patent ductus arteriosus in preterm infants: a randomized clinical trial. JAMA Pediatr 174:755\u2013763","journal-title":"JAMA Pediatr"},{"key":"6130_CR12","doi-asserted-by":"publisher","first-page":"F99","DOI":"10.1136\/archdischild-2013-304695","volume":"99","author":"M Kluckow","year":"2014","unstructured":"Kluckow M, Jeffery M, Gill A, Evans N (2014) A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99:F99\u2013F104","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6130_CR13","first-page":"187","volume":"38","author":"V Khuwuthyakorn","year":"2018","unstructured":"Khuwuthyakorn V, Jatuwattana C, Silvilairat S, Tantiprapha W (2018) Oral indomethacin versus oral ibuprofen for treatment of patent ductus arteriosus: a randomised controlled study in very low-birthweight infants. Paediatr Int Child Health 38:187\u2013192","journal-title":"Paediatr Int Child Health"},{"key":"6130_CR14","doi-asserted-by":"publisher","first-page":"F179","DOI":"10.1136\/fn.76.3.F179","volume":"76","author":"B Van Overmeire","year":"1997","unstructured":"Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ (1997) Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 76:F179\u2013F184","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6130_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpeds.2016.04.066","volume":"177","author":"P H\u00e4rkin","year":"2016","unstructured":"H\u00e4rkin P et al (2016) Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Pediatr 177:72-77.e2","journal-title":"J Pediatr"},{"key":"6130_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2020.12.008","volume":"233","author":"J-C Roz\u00e9","year":"2021","unstructured":"Roz\u00e9 J-C et al (2021) Effect of early targeted treatment of ductus arteriosus with ibuprofen on survival without cerebral palsy at 2 years in infants with extreme prematurity: a randomized clinical trial. J Pediatr 233:33-42.e2","journal-title":"J Pediatr"},{"key":"6130_CR17","doi-asserted-by":"publisher","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","volume":"8","author":"D Dang","year":"2013","unstructured":"Dang D et al (2013) Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS ONE 8:e77888","journal-title":"PLoS ONE"},{"key":"6130_CR18","doi-asserted-by":"publisher","unstructured":"Noori NM, Teimouri A, Dehvari A, Bagheie S, Ansari H (2023) The effect of oral acetaminophen on open arterial duct closure in premature infants less than 32 weeks. Rom J Cardiol. https:\/\/doi.org\/10.2478\/rjc-2023-0007","DOI":"10.2478\/rjc-2023-0007"},{"key":"6130_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1203\/00006450-200001000-00009","volume":"47","author":"J Patel","year":"2000","unstructured":"Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD (2000) Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 47:36\u201342","journal-title":"Pediatr Res"},{"key":"6130_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0300060517722698","volume":"46","author":"M Al-Lawama","year":"2018","unstructured":"Al-Lawama M, Alammori I, Abdelghani T, Badran E (2018) Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res 46:811\u2013818","journal-title":"J Int Med Res"},{"key":"6130_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1157\/13078483","volume":"63","author":"A Gimeno Navarro","year":"2005","unstructured":"Gimeno Navarro A et al (2005) Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants. An. Pediatr (Barc) 63:212\u2013218","journal-title":"An. Pediatr (Barc)"},{"key":"6130_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-2007-976550","volume":"24","author":"H Aly","year":"2007","unstructured":"Aly H et al (2007) Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol 24:267\u2013270","journal-title":"Am J Perinatol"},{"key":"6130_CR23","first-page":"2596","volume":"18","author":"Y-J Ding","year":"2014","unstructured":"Ding Y-J, Han B, Yang B, Zhu M (2014) NT-proBNP plays an important role in the effect of ibuprofen on preterm infants with patent ductus arteriosus. Eur Rev Med Pharmacol Sci 18:2596\u20132598","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6130_CR24","first-page":"42","volume":"24","author":"E Pistulli","year":"2014","unstructured":"Pistulli E et al (2014) The association between patent ductus arteriosus and perinatal infection in a group of low birth weight preterm infants. Iran J Pediatr 24:42\u201348","journal-title":"Iran J Pediatr"},{"key":"6130_CR25","first-page":"2119","volume":"30","author":"N Demir","year":"2017","unstructured":"Demir N, Peker E, Ece \u0130, Balahoro\u011flu R, Tuncer O (2017) Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants. J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 30:2119\u20132125","journal-title":"J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"6130_CR26","doi-asserted-by":"publisher","first-page":"e3975","DOI":"10.5812\/ijp.3975","volume":"26","author":"MM Bagheri","year":"2016","unstructured":"Bagheri MM et al (2016) Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran J Pediatr 26:e3975","journal-title":"Iran J Pediatr"},{"key":"6130_CR27","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3892\/etm.2016.3676","volume":"12","author":"B Yang","year":"2016","unstructured":"Yang B, Gao X, Ren Y, Wang Y, Zhang Q (2016) Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial. Exp. Ther. Med. 12:2531\u20132536","journal-title":"Exp. Ther. Med."},{"key":"6130_CR28","first-page":"7","volume":"19","author":"P Sadeghi-Moghaddam","year":"2017","unstructured":"Sadeghi-Moghaddam P, Arjmandnia MH, Heidari A, Mohagheghi-Kamal SM, Aghaali M (2017) Comparison of therapeutic effects and side effects of oral ibuprofen and indomethacin on the closure of patent ductus arteriosus in premature infants. J Babol Univ Med Sci 19:7\u201312","journal-title":"J Babol Univ Med Sci"},{"key":"6130_CR29","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.15419\/bmrat.v5i02.418","volume":"5","author":"H Babaei","year":"2018","unstructured":"Babaei H, Nemati R, Daryoshi H (2018) Closure of patent ductus arteriosus with oral acetaminophen in preterm neonates: a randomized trial. Biomed Res Ther 5:2034\u20132044","journal-title":"Biomed Res Ther"},{"key":"6130_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","volume":"176","author":"AE-R El-Mashad","year":"2017","unstructured":"El-Mashad AE-R, El-Mahdy H, El Amrousy D, Elgendy M (2017) Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr 176:233\u2013240","journal-title":"Eur J Pediatr"},{"issue":"4","key":"6130_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5812\/ijp.11735","volume":"28","author":"M-M Bagheri","year":"2018","unstructured":"Bagheri M-M et al (2018) Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial. Iran J Pediatr 28(4):21","journal-title":"Iran J Pediatr"},{"key":"6130_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4103\/jcn.JCN_47_18","volume":"7","author":"N Asadpour","year":"2018","unstructured":"Asadpour N, Harandi PS, Hamidi M, Ahmadi MRMM, Malekpour-Tehrani A (2018) Comparison of the effect of oral acetaminophen and ibuprofen on patent ductus arteriosus closure in premature infants referred to Hajar hospital in Shahrekord in 2016\u20132017. J Clin Neonatol 7:224\u2013230","journal-title":"J Clin Neonatol"},{"key":"6130_CR33","first-page":"13","volume":"24","author":"M Ghaderian","year":"2019","unstructured":"Ghaderian M, Armanian AM, Sabri MR, Montaseri M (2019) Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates. J Res Med Sci Off J Isfahan Univ Med Sci 24:13","journal-title":"J Res Med Sci Off J Isfahan Univ Med Sci"},{"key":"6130_CR34","first-page":"605","volume":"48","author":"R Oboodi","year":"2020","unstructured":"Oboodi R et al (2020) Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus. Turk Kardiyol Dern Ars 48:605\u2013612","journal-title":"Turk Kardiyol Dern Ars"},{"key":"6130_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/apc.APC_115_19","volume":"13","author":"V Meena","year":"2020","unstructured":"Meena V, Meena DS, Rathore PS, Chaudhary S, Soni JP (2020) Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates - a randomized controlled trial. Ann Pediatr Cardiol 13:130\u2013135","journal-title":"Ann Pediatr Cardiol"},{"key":"6130_CR36","first-page":"1587","volume":"33","author":"B Balachander","year":"2020","unstructured":"Balachander B et al (2020) Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial. J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 33:1587\u20131592","journal-title":"J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"6130_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2020.01.058","volume":"222","author":"A Kumar","year":"2020","unstructured":"Kumar A et al (2020) Oral paracetamol vs. oral ibuprofen in patent ductus arteriosus: a randomized, controlled, noninferiority trial. J Pediatr 222:79\u2013842","journal-title":"J Pediatr"},{"key":"6130_CR38","doi-asserted-by":"publisher","unstructured":"Arif M, Afridi AS, Ali F, Buneri SUA, Salman M (2021) Comparison of efficacy of oral ibuprofen versus paracetamol for PDA closure in preterm neonates. Pak J Med Health Sci. 15(8):2529\u201332. https:\/\/doi.org\/10.53350\/pjmhs211582529","DOI":"10.53350\/pjmhs211582529"},{"key":"6130_CR39","doi-asserted-by":"publisher","first-page":"807712","DOI":"10.3389\/fped.2021.807712","volume":"9","author":"MC Bravo","year":"2021","unstructured":"Bravo MC et al (2021) Randomized trial on echocardiography-guided ductus arteriosus treatment to reduce necrotizing enterocolitis. Front Pediatr 9:807712","journal-title":"Front Pediatr"},{"key":"6130_CR40","doi-asserted-by":"publisher","unstructured":"Samadi M, Mirnia K, Nabaie Z, Salek Maghsoudi A, Aliakbari Khoei R, Parizad R (2022) Comparison of oral paracetamol with oral ibuprofen in closing patent ductus arteriosus in premature neonates: a randomized controlled trial. Crescent J Med Biol Sci. 9:(2):98\u2013103. https:\/\/doi.org\/10.34172\/cjmb.2022.17","DOI":"10.34172\/cjmb.2022.17"},{"key":"6130_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jpeds.2020.10.024","volume":"229","author":"A El-Khuffash","year":"2021","unstructured":"El-Khuffash A et al (2021) A pilot randomized controlled trial of early targeted patent ductus arteriosus treatment using a risk based severity score (the PDA RCT). J Pediatr 229:127\u2013133","journal-title":"J Pediatr"},{"key":"6130_CR42","first-page":"93","volume":"41","author":"JM Davidson","year":"2021","unstructured":"Davidson JM et al (2021) A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants. J Perinatol Off J Calif Perinat Assoc 41:93\u201399","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"key":"6130_CR43","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00246-014-0861-2","volume":"35","author":"S Yadav","year":"2014","unstructured":"Yadav S et al (2014) Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatr Cardiol 35:824\u2013830","journal-title":"Pediatr Cardiol"},{"key":"6130_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000450822","volume":"111","author":"YJ Lin","year":"2017","unstructured":"Lin YJ et al (2017) Randomized trial to compare renal function and ductal response between indomethacin and ibuprofen treatment in extremely low birth weight infants. Neonatology 111:195\u2013202","journal-title":"Neonatology"},{"key":"6130_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1542\/peds.112.2.345","volume":"112","author":"J Lee","year":"2003","unstructured":"Lee J et al (2003) Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 112:345\u2013350","journal-title":"Pediatrics"},{"key":"6130_CR46","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0022-3476(05)83342-6","volume":"117","author":"C Hammerman","year":"1990","unstructured":"Hammerman C, Aramburo MJ (1990) Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 117:771\u2013776","journal-title":"J Pediatr"},{"key":"6130_CR47","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1542\/peds.2004-1178","volume":"115","author":"C Dani","year":"2005","unstructured":"Dani C et al (2005) Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 115:1529\u20131535","journal-title":"Pediatrics"},{"key":"6130_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","volume":"164","author":"MY Oncel","year":"2014","unstructured":"Oncel MY et al (2014) Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 164:510\u20134.e1","journal-title":"J Pediatr"},{"key":"6130_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpeds.2008.01.031","volume":"153","author":"P Jegatheesan","year":"2008","unstructured":"Jegatheesan P et al (2008) Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr 153:183\u2013189","journal-title":"J Pediatr"},{"key":"6130_CR50","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0022-3476(99)70239-8","volume":"134","author":"O Tammela","year":"1999","unstructured":"Tammela O et al (1999) Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. J Pediatr 134:552\u2013557","journal-title":"J Pediatr"},{"key":"6130_CR51","doi-asserted-by":"publisher","first-page":"F477","DOI":"10.1136\/fn.88.6.F477","volume":"88","author":"DA Osborn","year":"2003","unstructured":"Osborn DA, Evans N, Kluckow M (2003) Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 88:F477\u2013F482","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6130_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000515415","volume":"118","author":"T Schindler","year":"2021","unstructured":"Schindler T et al (2021) Early PARacetamol (EPAR) trial: a randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatology 118:274\u2013281","journal-title":"Neonatology"},{"key":"6130_CR53","doi-asserted-by":"publisher","first-page":"F279","DOI":"10.1136\/archdischild-2011-300532","volume":"97","author":"O Erdeve","year":"2012","unstructured":"Erdeve O et al (2012) Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 97:F279\u2013F283","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6130_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0028-1103515","volume":"26","author":"JV Aranda","year":"2009","unstructured":"Aranda JV et al (2009) A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 26:235\u2013245","journal-title":"Am J Perinatol"},{"key":"6130_CR55","first-page":"102","volume":"39","author":"M Kluckow","year":"2019","unstructured":"Kluckow M et al (2019) A pilot randomised blinded placebo-controlled trial of paracetamol for later treatment of a patent ductus arteriosus. J Perinatol Off J Calif Perinat Assoc 39:102\u2013107","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"key":"6130_CR56","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/S0140-6736(04)17476-X","volume":"364","author":"V Gournay","year":"2004","unstructured":"Gournay V et al (2004) Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet (London, England) 364:1939\u20131944","journal-title":"Lancet (London, England)"},{"key":"6130_CR57","doi-asserted-by":"publisher","first-page":"e1256","DOI":"10.1542\/peds.2008-1780","volume":"122","author":"A Cherif","year":"2008","unstructured":"Cherif A et al (2008) Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 122:e1256\u2013e1261","journal-title":"Pediatrics"},{"key":"6130_CR58","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1203\/00006450-199512000-00010","volume":"38","author":"B van Overmeire","year":"1995","unstructured":"van Overmeire B et al (1995) Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr Res 38:886\u2013891","journal-title":"Pediatr Res"},{"key":"6130_CR59","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/S0140-6736(04)17477-1","volume":"364","author":"B Van Overmeire","year":"2004","unstructured":"Van Overmeire B et al (2004) Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet (London, England) 364:1945\u20131949","journal-title":"Lancet (London, England)"},{"key":"6130_CR60","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1055\/s-0035-1551671","volume":"32","author":"S Pourarian","year":"2015","unstructured":"Pourarian S, Takmil F, Cheriki S, Amoozgar H (2015) The effect of oral high-dose ibuprofen on patent ductus arteriosus closure in preterm infants. Am J Perinatol 32:1158\u20131163","journal-title":"Am J Perinatol"},{"key":"6130_CR61","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1203\/PDR.0b013e31817d9bb0","volume":"64","author":"C Hammerman","year":"2008","unstructured":"Hammerman C et al (2008) Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration? Pediatr Res 64:291\u2013297","journal-title":"Pediatr Res"},{"key":"6130_CR62","first-page":"314","volume":"89","author":"V Sangtawesin","year":"2006","unstructured":"Sangtawesin V et al (2006) Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai 89:314\u2013321","journal-title":"J Med Assoc Thai"},{"key":"6130_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/archdischild-2022-323781","volume":"108","author":"H Balasubramanian","year":"2023","unstructured":"Balasubramanian H et al (2023) Low dose paracetamol for management of patent ductus arteriosus in very preterm infants: a randomised non-inferiority trial. Arch Dis Child Fetal Neonatal Ed 108:130\u2013135","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6130_CR64","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/clpt.2011.284","volume":"91","author":"C Dani","year":"2012","unstructured":"Dani C et al (2012) High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther 91:590\u2013596","journal-title":"Clin Pharmacol Ther"},{"key":"6130_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000355679","volume":"105","author":"P Lago","year":"2014","unstructured":"Lago P et al (2014) Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants. Neonatology 105:46\u201354","journal-title":"Neonatology"},{"key":"6130_CR66","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13312-015-0677-z","volume":"52","author":"SK Dash","year":"2015","unstructured":"Dash SK et al (2015) Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial. Indian Pediatr 52:573\u2013578","journal-title":"Indian Pediatr"},{"key":"6130_CR67","doi-asserted-by":"publisher","first-page":"F94","DOI":"10.1136\/adc.2007.120584","volume":"93","author":"B-H Su","year":"2008","unstructured":"Su B-H et al (2008) Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 93:F94\u2013F99","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6130_CR68","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00431-002-0915-y","volume":"161","author":"P Lago","year":"2002","unstructured":"Lago P et al (2002) Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161:202\u2013207","journal-title":"Eur J Pediatr"},{"key":"6130_CR69","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00228-012-1438-8","volume":"69","author":"G Kanmaz","year":"2013","unstructured":"Kanmaz G et al (2013) Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus. Eur J Clin Pharmacol 69:1075\u20131081","journal-title":"Eur J Clin Pharmacol"},{"key":"6130_CR70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/adc.58.4.267","volume":"58","author":"P Rudd","year":"1983","unstructured":"Rudd P, Montanez P, Hallidie-Smith K, Silverman M (1983) Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child 58:267\u2013270","journal-title":"Arch Dis Child"},{"key":"6130_CR71","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s004310051288","volume":"159","author":"MP De Carolis","year":"2000","unstructured":"De Carolis MP et al (2000) Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 159:364\u2013368","journal-title":"Eur J Pediatr"},{"issue":"Suppl 3","key":"6130_CR72","first-page":"S28","volume":"91","author":"C Sangtawesin","year":"2008","unstructured":"Sangtawesin C et al (2008) Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants. J Med Assoc Thai 91(Suppl 3):S28-34","journal-title":"J Med Assoc Thai"},{"key":"6130_CR73","first-page":"360","volume":"14","author":"S Pourarian","year":"2008","unstructured":"Pourarian S, Pishva N, Madani A, Rastegari M (2008) Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. East Mediterr Heal J La Rev sante la Mediterr Orient al-Majallah al-sihhiyah li-sharq al-mutawassit 14:360\u2013365","journal-title":"East Mediterr Heal J La Rev sante la Mediterr Orient al-Majallah al-sihhiyah li-sharq al-mutawassit"},{"key":"6130_CR74","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1056\/NEJM200009073431001","volume":"343","author":"B Van Overmeire","year":"2000","unstructured":"Van Overmeire B et al (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674\u2013681","journal-title":"N Engl J Med"},{"key":"6130_CR75","doi-asserted-by":"publisher","first-page":"394632023115299","DOI":"10.1177\/03946320231152993","volume":"37","author":"J-J Pan","year":"2023","unstructured":"Pan J-J, Yang Y, Cui S-D, Chen X-Q, Zhou X-G (2023) Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: a pilot study. Int J Immunopathol Pharmacol 37:3946320231152993","journal-title":"Int J Immunopathol Pharmacol"},{"key":"6130_CR76","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1442-200X.2003.01797.x","volume":"45","author":"P-H Su","year":"2003","unstructured":"Su P-H, Chen J-Y, Su C-M, Huang T-C, Lee H-S (2003) Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 45:665\u2013670","journal-title":"Pediatr Int"},{"key":"6130_CR77","first-page":"399","volume":"9","author":"SH Fakhraee","year":"2007","unstructured":"Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R (2007) Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 9:399\u2013403","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"6130_CR78","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.chest.2021.07.009","volume":"160","author":"YA Khan","year":"2021","unstructured":"Khan YA, Fan E, Ferguson ND (2021) Precision medicine and heterogeneity of treatment effect in therapies for ARDS. Chest 160:1729\u20131738","journal-title":"Chest"},{"key":"6130_CR79","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00431-023-04882-9","volume":"182","author":"FY Matsushita","year":"2023","unstructured":"Matsushita FY, Krebs VLJ, de Carvalho WB (2023) Identifying two distinct subphenotypes of patent ductus arteriosus in preterm infants using machine learning. Eur J Pediatr 182:2173\u20132179","journal-title":"Eur J Pediatr"},{"key":"6130_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04298-3","author":"FY Matsushita","year":"2021","unstructured":"Matsushita FY, Krebs VLJ, de Carvalho WB (2021) Identifying clinical phenotypes in extremely low birth weight infants\u2014an unsupervised machine learning approach. Eur J Pediatr. https:\/\/doi.org\/10.1007\/s00431-021-04298-3","journal-title":"Eur J Pediatr"},{"key":"6130_CR81","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1590\/1806-9282.20220177","volume":"68","author":"FY Matsushita","year":"2022","unstructured":"Matsushita FY, Krebs VLJ, de Carvalho WB (2022) Artificial intelligence and machine learning in pediatrics and neonatology healthcare. Revista da Associacao Medica Brasileira 68:745\u2013750","journal-title":"Revista da Associacao Medica Brasileira"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06130-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T11:01:13Z","timestamp":1749380473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6130"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06130-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4991342\/v1","asserted-by":"object"}]},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"300"}}